Literature DB >> 426710

Osteogenesis imperfecta. A study of 160 family members.

R W Quisling, G R Moore, R A Jahrsdoerfer, R W Cantrell.   

Abstract

Osteogenesis imperfecta, a genetic disease characterized by blue sclera, fragile bones, and hearing loss, was studied in 160 descendants of a single, affected individual. One hundred twenty family members in four generations were at risk of inheriting the gene for osteogenesis imperfecta. Fifty-six percent (68/120) had blue sclera, and, of this group, 66% had fragile bones, and 47% of those tested had hearing loss. The onset of hearing loss was usually in the second or third decade, and was primarily of the conductive type. The incidence of sensorineural hearing loss was only slightly less than the incidence of conductive hearing loss. To out knowledge, this is the largest reported kindred study of osteogenesis imperfecta. The genetic transmission of this disease as an autosomal dominant was confirmed.

Entities:  

Mesh:

Year:  1979        PMID: 426710     DOI: 10.1001/archotol.1979.00790160041011

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  3 in total

1.  Osteogenesis Imperfecta: the audiological phenotype lacks correlation with the genotype.

Authors:  Freya K R Swinnen; Paul J Coucke; Anne M De Paepe; Sofie Symoens; Fransiska Malfait; Filomena V Gentile; Luca Sangiorgi; Patrizia D'Eufemia; Mauro Celli; Ton J T M Garretsen; Cor W R J Cremers; Ingeborg J M Dhooge; Els M R De Leenheer
Journal:  Orphanet J Rare Dis       Date:  2011-12-29       Impact factor: 4.123

2.  Hearing loss in osteogenesis imperfecta: characteristics and treatment considerations.

Authors:  Joseph P Pillion; David Vernick; Jay Shapiro
Journal:  Genet Res Int       Date:  2011-12-14

3.  Closed rhinoseptoplasty in patient with Van der Hoeve-De Klein Syndrome.

Authors:  Raíssa Ferreira Gonçalves; Rafael Alves Cordeiro; Charisse Assuane de Araujo Patrício; Camila Atallah Pontes da Silva; Priscila Bogar Rapoport
Journal:  Braz J Otorhinolaryngol       Date:  2014 May-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.